InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: Theburg post# 2322

Wednesday, 03/22/2017 10:03:02 AM

Wednesday, March 22, 2017 10:03:02 AM

Post# of 21531
I agree burg, I would think that Dr. Alkon has had, by now, a number of anecdotal reports about the Ph2b study and that is reflected in the tone and conviction of his presentation.

The company is looking ahead at spending money on a continuation open label Ph2b study, a Ph3 study, and a Fragile X study. Not the type of planning you would expect if the signs were not good.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News